2023 Q4 Form 10-Q Financial Statement

#000165324723000072 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.654M
YoY Change -76.87%
Cash & Equivalents $4.654M
Short-Term Investments
Other Short-Term Assets $1.868M
YoY Change -63.94%
Inventory
Prepaid Expenses
Receivables $2.718M
Other Receivables $0.00
Total Short-Term Assets $10.81M
YoY Change -63.82%
LONG-TERM ASSETS
Property, Plant & Equipment $264.0K
YoY Change -87.89%
Goodwill $0.00
YoY Change -100.0%
Intangibles $5.828M
YoY Change -85.94%
Long-Term Investments
YoY Change
Other Assets $713.0K
YoY Change -16.9%
Total Long-Term Assets $10.77M
YoY Change -82.27%
TOTAL ASSETS
Total Short-Term Assets $10.81M
Total Long-Term Assets $10.77M
Total Assets $21.59M
YoY Change -76.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.353M
YoY Change -26.23%
Accrued Expenses $13.68M
YoY Change -2.45%
Deferred Revenue
YoY Change
Short-Term Debt $57.01M
YoY Change 4557.27%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $79.52M
YoY Change 178.25%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $13.00K
YoY Change -35.0%
Total Long-Term Liabilities $13.00K
YoY Change -35.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.52M
Total Long-Term Liabilities $13.00K
Total Liabilities $80.65M
YoY Change -7.1%
SHAREHOLDERS EQUITY
Retained Earnings -$601.6M
YoY Change 13.18%
Common Stock $542.5M
YoY Change 1.34%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$59.07M
YoY Change
Total Liabilities & Shareholders Equity $21.59M
YoY Change -76.19%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4654000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12066000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2718000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3982000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1574000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
1559000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1868000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5997000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
10814000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23604000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
264000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2917000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
713000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
812000 usd
CY2023Q3 us-gaap Assets
Assets
21585000 usd
CY2022Q4 us-gaap Assets
Assets
48145000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3353000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5689000 usd
CY2023Q3 wtrh Restaurant Food Liability Current
RestaurantFoodLiabilityCurrent
594000 usd
CY2022Q4 wtrh Restaurant Food Liability Current
RestaurantFoodLiabilityCurrent
1282000 usd
CY2023Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
474000 usd
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1672000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
92000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
74000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
573000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1023000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17429000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17596000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
79520000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
29228000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1117000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2079000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
80650000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
85236000 usd
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
249000000 shares
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-575924000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-59065000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37091000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21585000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48145000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11480000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25141000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42135000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91352000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
4797000 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13457000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
19020000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
49719000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3829000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8263000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12026000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
21489000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
858000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
935000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2801000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3488000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5210000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7762000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19626000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31520000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
390000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3599000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1268000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9664000 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
53898000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9536000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
121088000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.00
wtrh Number Of Shares Issuable On Conversion Of Convertible Securities
NumberOfSharesIssuableOnConversionOfConvertibleSecurities
264616 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001653247
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2021Q2 wtrh One Time Payment In Settlement Agreement Extension Period
OneTimePaymentInSettlementAgreementExtensionPeriod
P8M
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Registrant Name
EntityRegistrantName
WAITR HOLDINGS INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3828008
dei Entity Address Address Line1
EntityAddressAddressLine1
214 Jefferson Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Lafayette
dei Entity Address State Or Province
EntityAddressStateOrProvince
LA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
70501
dei City Area Code
CityAreaCode
337
dei Local Phone Number
LocalPhoneNumber
534-6881
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13545285 shares
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
808000 usd
CY2023Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
2278000 usd
CY2022Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
3403000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
0 usd
CY2022Q4 us-gaap Goodwill
Goodwill
9536000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5828000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7065000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1688000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
249000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13544329 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13544329 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12955299 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12955299 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
21000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
21000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
542464000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
538812000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-601550000 usd
CY2023Q3 wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
500000 usd
CY2022Q3 wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
0 usd
wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
500000 usd
wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
0 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
10000 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-55000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
32000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
15574000 usd
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
87969000 usd
us-gaap Costs And Expenses
CostsAndExpenses
64745000 usd
us-gaap Costs And Expenses
CostsAndExpenses
236935000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4094000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-62828000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-22610000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-145583000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
961000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
1198000 usd
us-gaap Interest Expense
InterestExpense
2836000 usd
us-gaap Interest Expense
InterestExpense
4363000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-146000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9422000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-162000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-12356000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5201000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73448000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25608000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-162302000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5206000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-73462000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25626000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162349000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.55
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13531845 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13531845 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9188320 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9188320 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13485092 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13485092 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8304321 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8304321 shares
us-gaap Net Income Loss
NetIncomeLoss
-25626000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162349000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2785000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1417000 usd
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 usd
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
9499000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3513000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4588000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
32000 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
33000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1268000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9664000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
9536000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
121088000 usd
wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
500000 usd
wtrh Intangible And Other Asset Impairments
IntangibleAndOtherAssetImpairments
0 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
1178000 usd
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
930000 usd
wtrh Gain Loss On Lease Modification
GainLossOnLeaseModification
135000 usd
wtrh Gain Loss On Lease Modification
GainLossOnLeaseModification
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-551000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-47000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-80000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1264000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
75000 usd
wtrh Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
68000 usd
wtrh Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
1563000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4129000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3526000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-95000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-229000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2336000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2473000 usd
wtrh Increase Decrease In Restaurant Food Liability
IncreaseDecreaseInRestaurantFoodLiability
-688000 usd
wtrh Increase Decrease In Restaurant Food Liability
IncreaseDecreaseInRestaurantFoodLiability
-1666000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
18000 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
47000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-1198000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-1618000 usd
wtrh Increased Decrease In Accrued Medical Contingency
IncreasedDecreaseInAccruedMedicalContingency
0 usd
wtrh Increased Decrease In Accrued Medical Contingency
IncreasedDecreaseInAccruedMedicalContingency
-53000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-174000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3054000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-4000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
826000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6022000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21701000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
224000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6335000 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
27000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
51000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
56000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
49000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6530000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
155000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10266000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
164000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20000000 usd
wtrh Proceeds From Short Term Loans
ProceedsFromShortTermLoans
625000 usd
wtrh Proceeds From Short Term Loans
ProceedsFromShortTermLoans
2811000 usd
wtrh Repayment Of Short Term Debt Excluding Line Of Credit And Short Term Notes Payments
RepaymentOfShortTermDebtExcludingLineOfCreditAndShortTermNotesPayments
2035000 usd
wtrh Repayment Of Short Term Debt Excluding Line Of Credit And Short Term Notes Payments
RepaymentOfShortTermDebtExcludingLineOfCreditAndShortTermNotesPayments
4729000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
106000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1439000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11762000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7412000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-39993000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12066000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
60111000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4654000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20118000 usd
us-gaap Interest Paid Net
InterestPaidNet
51000 usd
us-gaap Interest Paid Net
InterestPaidNet
2946000 usd
wtrh Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-470000 usd
wtrh Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-605000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
16949000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-54964000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5206000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1106000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-59065000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-37091000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25626000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
16000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3513000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
155000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-59065000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
57618000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-73462000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
79000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1338000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
15274000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3146000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3835000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
134489000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162349000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
106000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4588000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
16947000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10266000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
3835000 usd
us-gaap Nature Of Operations
NatureOfOperations
Organization<div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Waitr Holdings Inc., a Delaware corporation, together with its wholly owned subsidiaries (the “Company,” “ASAP,” “we,” “us” and “our”), operates an online ordering technology platform (the “Platform”), connecting restaurants, merchants and diners in certain cities in the United States. The Platform makes it easy for consumers to order food, convenience, grocery, flowers, auto parts and other items. In June 2023, the Company contracted with Uber Technologies Inc. (“Uber Technologies”) whereby Uber Direct, Uber Technologies’ delivery service, now provides the delivery services for items ordered on the Company’s Platform. The Company no longer provides delivery services through independent contractor drivers. Additionally, the Company facilitates access to third parties that provide payment processing solutions for restaurants and other merchants. We entered into the business of facilitating access to third parties that provide payment processing solutions through the acquisition of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC (collectively referred to herein as the “Cape Payment Companies”) in August 2021.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On November 18, 2022, the Company filed a Certificate of Amendment to amend the Company’s Third Amended and Restated Certificate of Incorporation, which effected a one for twenty (1:20) reverse stock split (the “Reverse Stock Split”) of its outstanding common stock. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 12 – Stockholders’</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information. All common share and per share amounts presented in the unaudited condensed consolidated financial statements and accompanying notes have been retroactively adjusted to reflect the Reverse Stock Split.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited condensed consolidated financial statements in accordance with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Significant estimates and judgments relied upon in preparing these condensed consolidated financial statements affect the following items:</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incurred loss estimates under our insurance policies with large deductibles or retention levels;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss exposure related to claims;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">determination of agent vs. principal classification for revenue recognition purposes;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">income taxes;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">useful lives of tangible and intangible assets;</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contingencies; and</span></div><div style="margin-top:3pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fair value of goodwill and other intangible assets, including the recoverability of intangible assets with finite lives and other long-lived assets.</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company regularly assesses these estimates and records changes to estimates in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions believed to be reasonable under the circumstances. Changes in the economic environment, financial markets, and any other parameters used in determining these estimates could cause actual results to differ from those estimates.</span></div>
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-601550000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12066000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4654000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11480000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25141000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
42135000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91352000 usd
CY2023Q3 wtrh Receivable Due From Credit Card Remittance
ReceivableDueFromCreditCardRemittance
763000 usd
CY2022Q4 wtrh Receivable Due From Credit Card Remittance
ReceivableDueFromCreditCardRemittance
2334000 usd
CY2021Q4 wtrh Receivable Due From Credit Card Remittance
ReceivableDueFromCreditCardRemittance
1354000 usd
CY2023Q3 wtrh Residual Commissions Receivable
ResidualCommissionsReceivable
1455000 usd
CY2022Q4 wtrh Residual Commissions Receivable
ResidualCommissionsReceivable
1422000 usd
CY2021Q4 wtrh Residual Commissions Receivable
ResidualCommissionsReceivable
1342000 usd
CY2023Q3 wtrh Trade Receivables Current
TradeReceivablesCurrent
747000 usd
CY2022Q4 wtrh Trade Receivables Current
TradeReceivablesCurrent
596000 usd
CY2021Q4 wtrh Trade Receivables Current
TradeReceivablesCurrent
660000 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
2965000 usd
CY2022Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
4352000 usd
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
3356000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
247000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
370000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
329000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2718000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3982000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3027000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6876000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2048000 usd
CY2023Q3 wtrh Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4828000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8376000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2048000 usd
CY2023Q3 wtrh Finite And Indefinite Lived Intangible Assets Accumulated Impairment
FiniteAndIndefiniteLivedIntangibleAssetsAccumulatedImpairment
500000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5828000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
143400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38233000 usd
CY2022Q4 wtrh Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
99602000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5565000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
146438000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
38233000 usd
CY2022Q4 wtrh Finite And Indefinite Lived Intangible Assets Accumulated Impairment
FiniteAndIndefiniteLivedIntangibleAssetsAccumulatedImpairment
101140000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
7065000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
246000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3091000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
737000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8041000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
248000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
953000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
876000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
873000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
867000 usd
CY2023Q3 wtrh Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
1011000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4828000 usd
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2022Q3 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2 reportingunit
CY2023Q3 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
7268000 usd
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
7139000 usd
CY2023Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
146000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
275000 usd
CY2023Q3 wtrh Accrued Medical Contingency Current
AccruedMedicalContingencyCurrent
366000 usd
CY2022Q4 wtrh Accrued Medical Contingency Current
AccruedMedicalContingencyCurrent
366000 usd
CY2023Q3 wtrh Accrued Legal Contingency Current
AccruedLegalContingencyCurrent
1250000 usd
CY2022Q4 wtrh Accrued Legal Contingency Current
AccruedLegalContingencyCurrent
1250000 usd
CY2023Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
602000 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
307000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3001000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3157000 usd
CY2023Q3 wtrh Unclaimed Property Current
UnclaimedPropertyCurrent
2911000 usd
CY2022Q4 wtrh Unclaimed Property Current
UnclaimedPropertyCurrent
2795000 usd
CY2023Q3 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
1885000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
2307000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17429000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
17596000 usd
CY2023Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
57005000 usd
CY2022Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
55793000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
961000 usd
CY2022Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1198000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
2836000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
4363000 usd
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
127.25
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
47000 usd
CY2023Q3 wtrh Number Of Amended Operating Lease Agreements
NumberOfAmendedOperatingLeaseAgreements
1 lease
CY2023Q3 wtrh Decrease In Lessee Operating Lease Liability To Be Paid Percent
DecreaseInLesseeOperatingLeaseLiabilityToBePaidPercent
0.22
wtrh Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-470000 usd
CY2023Q3 wtrh Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-470000 usd
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-605000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-605000 usd
wtrh Gain Loss On Lease Modification
GainLossOnLeaseModification
135000 usd
CY2023Q3 wtrh Gain Loss On Lease Modification
GainLossOnLeaseModification
135000 usd
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 usd
CY2023Q3 wtrh Outstanding Workers Compensation And Auto Policy Reserves
OutstandingWorkersCompensationAndAutoPolicyReserves
7414000 usd
CY2022Q4 wtrh Outstanding Workers Compensation And Auto Policy Reserves
OutstandingWorkersCompensationAndAutoPolicyReserves
7349000 usd
CY2021Q3 wtrh Cash Paid To Plaintiff
CashPaidToPlaintiff
4700000 usd
CY2021Q2 wtrh One Time Payment In Settlement Agreement
OneTimePaymentInSettlementAgreement
800000 usd
CY2022Q1 wtrh One Time Payment In Settlement Agreement
OneTimePaymentInSettlementAgreement
800000 usd
CY2022Q1 wtrh One Time Payment In Settlement Agreement Extension Period
OneTimePaymentInSettlementAgreementExtensionPeriod
P8M
wtrh One Time Payment In Settlement Agreement
OneTimePaymentInSettlementAgreement
800000 usd
CY2019Q2 wtrh Number Of Restaurant Partner
NumberOfRestaurantPartner
10000 partner
CY2021Q4 us-gaap Litigation Reserve
LitigationReserve
1250000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
249000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
249000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13544329 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13544329 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12955299 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12955299 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
127.25
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-5206000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-73462000 usd
us-gaap Net Income Loss
NetIncomeLoss
-25626000 usd
us-gaap Net Income Loss
NetIncomeLoss
-162349000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5206000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-5206000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73462000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-73462000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25626000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-25626000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-162349000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-162349000 usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13531845 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13531845 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9188320 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9188320 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13485092 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13485092 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8304321 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8304321 shares
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-19.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-19.55
wtrh Number Of Shares Issuable On Conversion Of Convertible Securities
NumberOfSharesIssuableOnConversionOfConvertibleSecurities
345704 shares

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
wtrh-20230930_cal.xml Edgar Link unprocessable
0001653247-23-000072-index-headers.html Edgar Link pending
0001653247-23-000072-index.html Edgar Link pending
0001653247-23-000072.txt Edgar Link pending
0001653247-23-000072-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wtrh-20230930.htm Edgar Link pending
wtrh-20230930.xsd Edgar Link pending
wtrh-20230930xexx311.htm Edgar Link pending
wtrh-20230930xexx312.htm Edgar Link pending
wtrh-20230930xexx321.htm Edgar Link pending
wtrh-20230930xexx322.htm Edgar Link pending
wtrh-20230930_def.xml Edgar Link unprocessable
wtrh-20230930_lab.xml Edgar Link unprocessable
wtrh-20230930_pre.xml Edgar Link unprocessable
wtrh-20230930_htm.xml Edgar Link completed